
⚠ COVID-19 INFORMATION: Resources, Vaccine Information
The goal of this prospective study is to assess the efficacy of pre-operative surgical site drug injection in pediatric patients with cerebral palsy undergoing hip surgery. Patients will be randomly assigned to the 2 treatment groups: surgical-site injection with ropivacaine, ketorolac, and epinephrine, or surgical-site injection with normal saline. The primary outcome measure will be total narcotic consumption in the first 48 hours after surgery. Pain scores during inpatient hospitalization following the surgical procedure, total narcotic consumption following hospital discharge, length of stay, parent satisfaction scores, and complications will also be analyzed.
Carly Strohbach
Clinical Research Coordinator III
312.227.6627